MentionFox
Home › funding signals › Vimy Pharmaceuticals Inc.
Form D · on the record

Vimy Pharmaceuticals Inc. — $278K Form D filing, November 2026

Before you sell to, join or invest in Vimy Pharmaceuticals Inc.

MentionFox check on Vimy Pharmaceuticals Inc.: only 1 source on file so far (checked 7 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/vimy-pharmaceuticals-inc-form-d-050479

Check Vimy Pharmaceuticals Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Vimy Pharmaceuticals Inc.?

Vimy Pharmaceuticals Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-06.

Vimy Pharmaceuticals Inc. filed a Form D notice of an exempt securities offering with the SEC on November 6, 2026. The filing reports $278K sold. Its industry group is Pharmaceuticals. It names David Suchon (Chief Executive Officer), Farris Smith (President and Chair), Darryl Firsten (Director) (SEC Form D, November 6, 2026).

Vimy Pharmaceuticals Inc. raised on Nov 6. 125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

5 more Pharmaceuticals raises within 90 days of this one ↓

Is this your company?

Key facts

Run the free check on Vimy Pharmaceuticals Inc. →

Sell to companies like Vimy Pharmaceuticals Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Vimy Pharmaceuticals Inc.

New Form D on file · 2026-11-06 · the record

$278K
raise on the record
D
filing
2
investors in
ONTARIO, CANADA
based
Open the record →

What the record says

FilingForm D
Filed2026-11-06
Industry groupPharmaceuticals
Entity typeCorporation
Incorporated inONTARIO, CANADA
Year formed2024
BasedTORONTO, ONTARIO, CANADA
CIK2159983
Accession0001493152-26-050479

Pitching, partnering or investing alongside them? See who really runs and owns Vimy Pharmaceuticals Inc.

Watch Vimy Pharmaceuticals Inc.: email me the next time it files something

Free to see. No signup.

Keep reading

More on the people and the money behind Vimy Pharmaceuticals Inc., from the filings we hold.

More raises like this

Pharmaceuticals raises filed within 90 days of this one, largest first.

What do you want to do with Vimy Pharmaceuticals Inc.?

Get the full cited report on Vimy Pharmaceuticals Inc.

What the filing shows about Vimy Pharmaceuticals Inc.

  • 2 investors had already put money in when it filed.
  • The filing names 5 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Vimy Pharmaceuticals Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Vimy Pharmaceuticals Inc.'s address as 2 Bloor Street West, Suite 2002, Toronto, A6 M4W1J5.

Full funding history for Vimy Pharmaceuticals Inc. →

What the filing says

  • Offered: $278,174. Sold: $278,174. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 2 had already invested. (filing)
  • Date of first sale: October 22, 2026. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • Securities that converted: the filing says “The Issuer sold subscription receipts, which will be converted into shares of the Issuer without consideration upon the closing of the transaction.” (filing)
  • On the amounts offered and sold: the filing adds “The total offering amount was $390,000 in Canadian dollars. The U.S. dollar value above is based on the Federal Reserve exchange rate on October 22, 2026, of $1.4020 CAD per USD.” (filing)
  • On sales commissions and finders' fees: the filing adds “Consists of an $8,345 cash fee and 3,900 stock options, each representing 3% of subscription receipts sold in the offering; total option value estimated at $1,892 using good faith Black-Scholes valuation on 11/6/26. CAD converted to USD at the rate above.” (filing)
  • On the business combination question: the filing adds “The Issuer sold subscription receipts, which will be converted into shares of the Issuer without consideration upon the closing of the transaction.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Vimy Pharmaceuticals Inc. See pricing

Is Vimy Pharmaceuticals Inc. a real, registered company?

Vimy Pharmaceuticals Inc. is a registered filer with the SEC (CIK 2159983) and has filed since 2026-10-13. 2 filings are on record, the latest on 2026-11-06.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Vimy Pharmaceuticals Inc.?

Vimy Pharmaceuticals Inc.'s Form D of 2026-11-06 names David Suchon, Farris Smith, Darryl Firsten and 2 more as its officers, directors or promoters.

How much has Vimy Pharmaceuticals Inc. raised?

Its new offerings report $1.29M sold across 2 offerings, as its own filings state.

Filing history · 2 filings on this registrant
Form D · 2026-10-13 · $1.01MForm D · 2026-11-06 · $278K · this page 2026-10-13 2026-11-06

Each marker is one filing. The larger marker is the filing this page is about.

Pharmaceuticals · by week
This raise, $278K, filed week of Nov 2

Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week. The dot is this raise, $278K, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Vimy Pharmaceuticals Inc.?

What the filing shows about Vimy Pharmaceuticals Inc.

  • 2 investors had already put money in when it filed.
  • The filing names 5 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Vimy Pharmaceuticals Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Vimy Pharmaceuticals Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Vimy Pharmaceuticals Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Vimy Pharmaceuticals Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Vimy Pharmaceuticals Inc.: Raised $278K, Form D filed 2026-11-06
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/vimy-pharmaceuticals-inc-form-d-050479
Last updated 2026-11-07
Primary record: SEC filing 1 · SEC filing 2
Vimy Pharmaceuticals Inc. raised $278K — SEC Form D filing, November 2026. MentionFox, 2026-11-07. https://mentionfox.com/funding/vimy-pharmaceuticals-inc-form-d-050479